(Q45273813)

English

Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy

scientific article

Statements

Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy (English)
Daniel Fuster
Jaime A Huertas
Guadalupe Gómez
Ricard Solà
Juan González García
Josep Vilaró
Enric Pedrol
Lluís Force
Jordi Tor
Guillem Sirera
Sebastiá Videla
Ramon Planas
Cristina Tural
PEG-TOX Research Group
1 January 2005
841-847

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit